Aspirin use for primary prevention among US adults with and without elevated Lipoprotein(a)

By sjmartinez • May 14, 2024

Razavi AC, Richardson LC, Coronado F, Dzaye O, Bhatia HS, Mehta A, Quyyumi AA, Vaccarino V, Budoff MJ, Nasir K, Tsimikas S, Whelton SP, Blaha MJ, Blumenthal RS, Sperling LS. Aspirin use for primary prevention among US adults with and without elevated Lipoprotein(a). Am J Prev Cardiol. 2024 Apr 27;18:100674. doi: 10.1016/j.ajpc.2024.100674. PMID: 38741703; PMCID: PMC11090055.

Tags: Aspirin, Cardiology/Epi, cardiovascular disease, Harbor UCLA, lipoprotein(a), NHANES, Publications

Evaluating associations of oxylipin metabolites and fatty acids with incident and prevalent type 2 diabetes in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)

Downie CG, Highland HM, Howard AG, Alotaibi M, Elfassy T, Cordero C, Below JE, Carnethon M, Cheng S, Daviglus M, Garcia-Bedoya O, Kaplan R, Khambaty[...]

Safety and Effectiveness of a Novel Laser-Based Intravascular Lithotripsy System for Coronary Calcium: FRACTURE Study

McEntegart M, Budrys P, Sharma S, Spratt JC, Nef H, Jefferson B, Verouden N, Corrigan FE 3rd, De Silva K, Chatterjee D, Price M, Webb[...]

Pulmonary Index of Microcirculatory Resistance: A Novel Hemodynamic Index for Invasively Assessing the Pulmonary Microvasculature

Parikh RV, Klomhaus A, Chen JY, Assi A, Bassam K, Channick R, Fearon WF, Aboulhosn J, Saggar R. Pulmonary Index of Microcirculatory Resistance: A Novel[...]